Posts

Transire Bio is selected in the top 15 of W.A. De Vigier Award! The next selection stage will involve evaluating business plans by the foundation’s experts and the new round of pitching to the foundation’s board in April.

Read the full press release at https://devigier.ch/press-release-top-15-2023/. Learn more about Bil De Vigier and W.A. De Vigier Foundation at https://devigier.ch/.

We are honored to have given our first official pitch with Transire Bio at the top 50 of W.A. De Vigier Award. We were selected among 310 applicants and we will have a chance to pitch in Soloturn in the Life Sciences & Biotech & Pharma cluster.

Read the press release at https://devigier.ch/press-release-selection-day-top50-2023/. Learn more about Bil De Vigier and W.A. De Vigier Foundation at https://devigier.ch/.

Transire Bio was selected to participate at SPARK Night Zurich. Our co-founders David and Nevena presented our technology and discussed open questions with the selected group of experts, investors and fellow entrepreneurs. SPARK Zurich provides a mentoring network for researchers with biotech projects. It is based on the SPARK program developed at Stanford University, which substantially increases the translational success rate of the ideas coming from academia.

Learn more about the Spark Night Zurich at https://www.sparkzurich.ch/.

Transire Bio represented by our co-founder Dr. Nevena Paunović, receives the prestigious ETH Pioneer Fellowship! The fellowship is generously supported by the ETH Foundation and is awarded to outstanding ETH students and postdoctoral fellows for the development of ground-breaking ideas. The fellowship involves financial support (CHF 150’000), infrastructure, coaching, network and visibility in order to accelerate the translation of a lab project towards the market.

Read more about our project at https://ethz-foundation.ch/en/pioneer-fellows/transire-bio/. Learn more about ETH Pioneer Fellowship at https://ethz.ch/en/industry/entrepreneurship/find-offers-programs-space-grants-for-entrepreneurs/pioneer-fellowship.html and about ETH Foundation at https://ethz-foundation.ch/en/.

OctoPatch^® invented by our co-founders Prof. Zhi Luo, Prof. Jean-Christophe Leroux and David Klein Cerrejon was selected in the top 20 patented inventions at ETH Zurich in 2022. The main criteria for the evaluation are originality, patent strength and market potential.

Learn more about the Spark Award at https://ethz.ch/en/industry/researchers/ip/sparkaward.html.